- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Intensive care unit
- Respiratory syncytial virus
- Respiratory syncytial virus infection
Central Data Repository
Explore the Central Data Repository: Use the filters and keyword search box on the left to find relevant studies. As you refine your search, the map and study list will automatically update to reflect your selections. Selecting a study from the list will provide detailed information about the specific study in question. A full legend can be found here
{content}
Study list
- Adults (18-64 years)
- General population
- Infants (<1 year)
- Children (1-11 years)
- Pregnant women
- Community
- Arbovirus
- Vector-borne disease
- Zika virus
- Arboviral disease
- Vector-borne disease
- Blood sample
- Urine sample
- Hair
- Saliva
- Semen
- Vaginal fluids
- Adults (18-64 years)
- People at high risk of STIs
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Blood sample
- Adults (18-64 years)
- General population
- Pregnant women
- Community
- Chlamydia trachomatis
- Sexually transmitted infection
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Blood sample
- Nasopharyngeal swab
- Nasal lining fluid sample
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- Hantavirus
- Puumala virus
- Hantavirus infection
- Adults (18-64 years)
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Emergency department
- Arbovirus
- Chikungunya virus
- Vector-borne
- Dengue virus
- Zika virus
- West Nile virus
- Japanese encephalitis virus
- Arboviral disease
- Vector-borne disease
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Fragile population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Palivizumab
- Adults (18-64 years)
- People at high risk of STIs
- Men who have sex with men
- People living with HIV
- Outpatient clinic
- STD/STI clinic
- Monkeypox virus
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- Mycoplasma spp.
- Ureaplasma
- Mpox
- Syphilis
- Chlamydia
- Gonorrhoea
- Mycoplasma infection
- Ureaplasma infection
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Hantavirus
- Puumala virus
- Hantaan virus
- Hantavirus infection
- Serum sample
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox